GlassScriptPhysician profile
Edgar Leclaire
NPI 1922149426
$2,757.17
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $303 · 2021: $637 · 2022: $727 · 2023: $338 · 2024: $134 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $780.72 | 2019-2022 | |
| Medtronic, INC. | $381.35 | 2021-2022 | |
| Axonics, INC. | $305.61 | 2021-2023 | Bulkamid |
| Abbvie INC. | $287.69 | 2022-2025 | |
| Astellas Pharma US INC | $235.59 | 2019-2023 | Myrbetriq |
| Medtronic USA, INC. | $189.73 | 2019-2020 | |
| Hologic Sales and Service, LLC | $121.82 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Boston Scientific Corporation | $118.21 | 2019-2025 | Advantage System, Axonics |
| Caldera Medical, INC | $97.70 | 2022 | |
| Myriad Women'S Health, INC. | $60.79 | 2023 | Myrisk |
| Ambu INC. | $45.34 | 2025 | |
| Minerva Surgical, INC | $36.77 | 2023 | |
| Ethicon US, LLC | $32.97 | 2023 | Enseal |
| Sumitomo Pharma America, INC. | $23.44 | 2023 | Gemtesa |
| Avion Pharmaceuticals | $21.47 | 2023 | Balcoltra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $17.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Leclaire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.